Last reviewed · How we verify

NCT03413423

Post Acute Cardiac Event Smoking (PACES) Study

Active, enrolled NA Last updated 15 September 2025
What this trial tests

NA trial testing BAT-CS in Acute Coronary Syndrome in 233 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
29 January 2018
Primary endpoint
8 May 2024
30 May 2026

Quick facts

Lead sponsorHennepin Healthcare Research Institute
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment233
Start date29 January 2018
Primary completion8 May 2024
Estimated completion30 May 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Hennepin Healthcare Research Institute

Who can join

Adults 18 to 75, any sex, with Acute Coronary Syndrome or Tobacco Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Summary of the Project : Quitting smoking following acute coronary syndrome (ACS) can reduce mortality up to 50%. However, depression and smoking are highly co-morbid and depressed mood may interfere with cessation and independently predicts mortality. Thus, a single, integrated treatment for both smoking and depression could be highly effective in reducing post-acute coronary syndrome mortality. Behavioral Activation (BA) is a well established treatment for depression and has recently shown promise as a treatment for smoking cessation. The investigators systematically developed an intervention integrating gold standard smoking cessation counseling with existing BA based mood management techniques for post-ACS smokers; Behavioral Activation Treatment for Cardiac Smokers (BAT-CS). Objective: For this R01 the investigators will evaluate the efficacy of using a single, integrated treatment that targets both depressed mood and smoking (BAT-CS).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Integrated smoking cessation and mood management following acute coronary syndrome: Protocol for the post-acute cardiac event smoking (PACES) trial.
    Adkins-Hempel M, Japuntich SJ, Chrastek M, Dunsiger S, et al · · 2023 · cited 4× · PMID 37173792 · DOI 10.1186/s13722-023-00388-9

Verify or expand the search:

Other recruiting trials for Acute Coronary Syndrome

Currently open trials in the same condition.

Other Hennepin Healthcare Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03413423.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing